BR9915148A - Mananase de coffea arábica - Google Patents

Mananase de coffea arábica

Info

Publication number
BR9915148A
BR9915148A BR9915148-0A BR9915148A BR9915148A BR 9915148 A BR9915148 A BR 9915148A BR 9915148 A BR9915148 A BR 9915148A BR 9915148 A BR9915148 A BR 9915148A
Authority
BR
Brazil
Prior art keywords
mannase
coffee
arabic coffee
arabic
arábica
Prior art date
Application number
BR9915148-0A
Other languages
English (en)
Inventor
Pierre Marraccini
John Rogers
Original Assignee
Produites Nestle S A Soc D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Produites Nestle S A Soc D filed Critical Produites Nestle S A Soc D
Publication of BR9915148A publication Critical patent/BR9915148A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C12N15/8246—Non-starch polysaccharides, e.g. cellulose, fructans, levans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/2488—Mannanases
    • C12N9/2494—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Patente de Invenção: <B>"MANANASE DE COFFEA ARáBICA"<D>. Fragmento de DNA oriundo de café codificando para pelo menos uma enzima implicada na hidrólise de polissacarídeos constituídos pelo menos de moléculas de mananos puras ou ramificadas ligadas entre si por uma ligação ß(1->4).
BR9915148-0A 1998-11-11 1999-10-28 Mananase de coffea arábica BR9915148A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203742 1998-11-11
PCT/EP1999/008314 WO2000028046A1 (fr) 1998-11-11 1999-10-28 Mannanase de coffea arabica

Publications (1)

Publication Number Publication Date
BR9915148A true BR9915148A (pt) 2001-08-07

Family

ID=8234304

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915148-0A BR9915148A (pt) 1998-11-11 1999-10-28 Mananase de coffea arábica

Country Status (4)

Country Link
US (1) US6841662B2 (pt)
EP (1) EP1131446A1 (pt)
BR (1) BR9915148A (pt)
WO (1) WO2000028046A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1138771A1 (fr) * 2000-03-30 2001-10-04 Societe Des Produits Nestle S.A. Endo-Mannanase de café
CN100370030C (zh) * 2006-01-25 2008-02-20 暨南大学 一种β-甘露聚糖酶基因及其编码产物的氨基酸序列和制备方法
US7678556B2 (en) * 2006-11-21 2010-03-16 Cornell Research Foundation, Inc. Beta-mannanase from coffee berry borer, Hypothenemus hampei, and uses thereof
JP2013521003A (ja) 2010-03-09 2013-06-10 ネステク ソシエテ アノニム コーヒーにおけるガラクトマンナン含有量の調整

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK48693D0 (da) * 1993-04-30 1993-04-30 Novo Nordisk As Enzym
US6329191B1 (en) * 1993-08-30 2001-12-11 Hawaii Biotechnology Group, Inc. DNA encoding recombinant coffee bean alpha-galactosidase
ES2137277T3 (es) * 1994-04-07 1999-12-16 Nestle Sa Hidrolisis de cafe, con una beta-mananasa inmovilizada.
US5874269A (en) * 1995-06-07 1999-02-23 University Of Hawaii Purified proteins, recombinant DNA sequences and processes for controlling the ripening of coffee plant
GB9524752D0 (en) * 1995-12-04 1996-02-07 Danisco Modification process

Also Published As

Publication number Publication date
US6841662B2 (en) 2005-01-11
EP1131446A1 (fr) 2001-09-12
US20020166145A1 (en) 2002-11-07
WO2000028046A1 (fr) 2000-05-18

Similar Documents

Publication Publication Date Title
ES2186855T3 (es) Laminas de vidrio destinadas a la fabricacion de acristalamientos.
WO1997026270A3 (en) Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules
BR9904939A (pt) Poliorganossilloxanos de enxofre-funcionais
BR0011030A (pt) Composições de cicloporina substancialmente livre de óleo
AU2001249423A1 (en) 38692 and 21117, novel dual specificity phosphatase molecules and uses therefor
PT1023194E (pt) Painel de vidro
WO2002068632A3 (en) Methods to identify mutant cells with altered sialic acid
TW200510528A (en) Polypeptide inducing apoptosis
WO2002068680A3 (en) Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes
WO1999065937A3 (en) Truncated apaf-1 and methods of use thereof
BR9915148A (pt) Mananase de coffea arábica
EP0914653A4 (en) TWO-SIDED DVD-CD HYBRID DISC
WO2001051523A3 (en) Anti-angiogenic proteins and fragments and methods of use thereof
AU1171102A (en) Uridine therapy for patients with elevated purine levels
BR0005411A (pt) Fixação de quarto dianteiro em travessa
AU3977699A (en) Ags proteins and nucleic acid molecules and uses therefor
BR9907383A (pt) Alfa-amilase maltogênica imobilizada e sua utilização na fabricação de um xarope rico em maltose
WO2003060478A3 (en) Methods and compositions for assaying homocysteine
Schwartz et al. International Federation of Clinical Chemistry, Education Committee and International Union of Pure and Applied Chemistry, Division of Clinical Chemistry: Definition of the terms certification, licensure and accreditation in clinical chemistry
BR0014167A (pt) Proteìna iren, sua preparação e aplicação
WO2001059075A8 (en) Improved sialylation of glycoproteins
MXPA03002581A (es) Composicion a base de copolicarbonatos.
WO2002060163A3 (en) Methods for increasing bone formation and enhancing bone accretion
EP0897008A3 (en) His5
WO2000009076A3 (en) Imaging with tc-99m labeled fibrin-alpha-chain peptide

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ARTIGO 37 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 19/00 (2006.01), A61K 8/60 (2006.0